Two Sigma Advisers’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
Other funds holding APTO
DS
NCM
CC
AC
VC
TWC
Two Sigma Advisers's APTO Position: Q2 2023 in Review
Two Sigma Advisers sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 157 shares — an estimated $45.1K sold.
Two Sigma Advisers first reported a position in APTO in Q2 2018 and held it in 20 quarters. The position peaked at $1.94M in Q2 2020. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.
- Two Sigma Advisers reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
- Two Sigma Advisers sold 157 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $45.1K.
- Two Sigma Advisers first reported a position in Aptose Biosciences, Inc. in Q2 2018 and held it in 20 quarters.
- Two Sigma Advisers's Aptose Biosciences, Inc. position peaked at $1.94M in Q2 2020.
- 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.
Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.